Emesis and Constipation Induced by Methadone and the Active Metabolite of Tramadol (M1) in Animals
Journal of Applied Toxicology · 2026
DOI: 10.1002/jat.4912 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2026. Verfasst von Tomohisa Mori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan. Hauptthemen laut MEDLINE: Tramadol, Methadone, Analgesics, Opioid, Vomiting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology of Japan, Ministry of Health, Labour and Welfare of Japan.
Abstract (Originalsprache)
Typical prescribed opioids are known to inhibit intestinal transit and induce emesis‐like behaviors in animals via distinct mechanisms and varying magnitudes. However, there is limited evidence regarding whether atypical opioids also produce these adverse effects in animals. This study was designed to investigate whether tramadol, its active metabolite O‐desmethyltramadol (M1), and methadone cause such side effects and to elucidate their underlying mechanisms. In ferrets, methadone and M1—but not tramadol and oxycodone—elicited adverse effects including emesis and tremor. Notably, the adverse effects associated with high‐dose methadone required urgent intervention with naloxone, indicating a more severe toxicity profile. The severity of emesis followed the rank order: M1 > methadone. In contrast to previous findings with morphine, M1‐induced retching was significantly inhibited by the selective dopamine D 2 receptor antagonist prochlorperazine, but not by the atypical antipsychotic olanzapine, suggesting a distinct receptor‐specific modulation. In mice, both methadone and high‐dose M1 significantly suppressed gastrointestinal transit. Notably, suppressed gastrointestinal transit induced by methadone and M1 exhibited different region‐specific mechanisms. Taken together with previous findings, the present results suggest that adverse effects caused by atypical opioids and those caused by typical opioids differ both mechanistically and pharmacologically. Recognizing these distinct profiles is essential for evaluating opioid‐induced adverse effects and can help refine clinical strategies. Ultimately, these insights may contribute to the development of evidence‐based interventions aimed at minimizing opioid‐related complications and improving the quality of life for patients receiving opioid‐based pain therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
- Laboratory on Mechanistic Control of Behavioral Plasticity, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
- Laboratory of Tissue Regeneration, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
- Pharmacology Laboratory, Pharmaceutical Department, Shonan University of Medical Sciences, Yokohama, Japan.
ORCID-Profile: Tomohisa Mori
Förderung
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- Ministry of Health, Labour and Welfare of Japan
Zitieren
APA
Mori, T., Shibasaki, M., Fukuma, E., Uzawa, N., & Suzuki, T. (2026). Emesis and Constipation Induced by Methadone and the Active Metabolite of Tramadol (M1) in Animals. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4912
Vancouver
Mori T, Shibasaki M, Fukuma E, Uzawa N, Suzuki T. Emesis and Constipation Induced by Methadone and the Active Metabolite of Tramadol (M1) in Animals. Journal of Applied Toxicology. 2026. doi:10.1002/jat.4912
BibTeX
@article{Mori2026,
author = {Mori, Tomohisa and Shibasaki, Masahiro and Fukuma, Erika and Uzawa, Naoki and Suzuki, Tsutomu},
title = {Emesis and Constipation Induced by Methadone and the Active Metabolite of Tramadol (M1) in Animals},
journal = {Journal of Applied Toxicology},
year = {2026},
doi = {10.1002/jat.4912}
}
EUVIMED